E-Paper
Biocon Q4 net profit up 25%
Top-listed biotechnology firm Biocon Ltd today reported a 25% rise in fourth-quarter profit as strong sales of its biopharmaceutical drugs helped offset muted sales at its German unit.
Updated on: Apr 28, 2011, 10:07:43 IST
Share via
Copy link
Top-listed biotechnology firm Biocon Ltd on Thursday reported a 25% rise in fourth-quarter profit as strong sales of its biopharmaceutical drugs helped offset muted sales at its German unit.
Bangalore-based Biocon had in January said revenue from its German arm AxiCorp would be pressured as it eliminated some low-margin drugs from its portfolio after the German government asked drugmakers to offer a rebate.
For the quarter ended March, consolidated net profit rose to 1.01 billion rupees ($22.78 million) from 806 million rupees reported a year earlier.
Shares in Biocon, valued at $1.7 billion have fallen 8.4% this year, steeper than the wider market's 5% fall.
Stay updated with the latest Business News on Petrol Price, Gold Rate, Silver Rates, Diesel Prices along with Income Tax Calculator
